SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?


To: phoenix_rising who wrote (1223)5/28/2015 6:52:15 PM
From: eico20  Read Replies (1) | Respond to of 2026
 
true, regarding French reimbursement and the injection, here's an excerpt from the HAS document:
would be good to know if the French news article is end of story or is there more, here’s an excerpt below from the HAS document: looks like this is what Caverject gets, maybe pricing is the only issue left

has-sante.fr

La Commission de transparence s’est prononcée favorablement pour le remboursement des IPDE 5 (SMR important) et des spécialités à base d’alprostadil par voie intra-caverneuse (SMR modéré) dans les dysfonctions érectiles liées aux pathologies suivantes : - paraplégie et tétraplégie quelle qu’en soit l’origine ; - traumatisme du bassin compliqué de troubles urinaires ; - séquelles de la chirurgie (anévrisme de l’aorte ; prostatectomie radicale, cystectomie totale et exérèse colorectale) ou de la radiothérapie abdominopelvienne ; - séquelles du priapisme ; - neuropathie diabétique avérée ; - sclérose en plaques.

Translation:

The Commission transparency rules favorably for the reimbursement of

IPDE 5 (important SMR) and specialties of alprostadil by intracavernous route ( SMR

moderate) in erectile dysfunction related to the following conditions :

- Paraplegia and quadriplegia whatever the origin ;

- Pelvic trauma complicated urinary problems ;

- Effects of surgery ( aortic aneurysm ; radical prostatectomy and radical cystectomy

- Colorectal resection ) or abdominopelvic radiation therapy ;

- Priapism sequelae ;

- Proven diabetic neuropathy ;

- Multiple sclerosis.